Marker Therapeutics logo

Marker Therapeutics share price today

(MRKR)

Marker Therapeutics share price is $3.12 & ₹267.73 as on 7 Jan 2025, 2.30 'hrs' IST

$3.12

-0.17

(-5.32%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Marker Therapeutics share price in Dollar and Rupees. Guide to invest in Marker Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Marker Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Marker Therapeutics share price movements

  • Today's Low: $3.03
    Today's High: $3.23

    Day's Volatility :6.14%

  • 52 Weeks Low: $2.44
    52 Weeks High: $5.99

    52 Weeks Volatility :59.3%

Marker Therapeutics Returns

PeriodMarker Therapeutics IncIndex (Russel 2000)
3 Months
25.1%
0.0%
6 Months
-33.54%
0.0%
1 Year
-33.4%
0.0%
3 Years
-60.85%
-19.8%

Marker Therapeutics Key Statistics

in dollars & INR

Previous Close
$3.29
Open
$3.29
Today's High
$3.23
Today's Low
$3.0318
Market Capitalization
$33.3M
Today's Volume
$29.3K
52 Week High
$5.99
52 Week Low
$2.4377
Revenue TTM
$3.7M
EBITDA
$-11.8M
Earnings Per Share (EPS)
$-1.07
Profit Margin
-278.22%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-71.74%

How to invest in Marker Therapeutics from India?

It is very easy for Indian residents to invest directly in Marker Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Marker Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Marker Therapeutics or MRKR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Marker Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Marker Therapeutics shares which would translate to 0.275 fractional shares of Marker Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Marker Therapeutics, in just a few clicks!

Returns in Marker Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Marker Therapeutics investment value today

Current value as on today

₹66,381

Returns

₹33,619

(-33.62%)

Returns from Marker Therapeutics Stock

₹36,842 (-36.84%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Marker Therapeutics

80%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Marker Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 80% more investors are searching Marker Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Marker Therapeutics

  • NEA Management Company, LLC

    12.01%

  • Aisling Capital Management LP

    3.52%

  • Vanguard Group Inc

    2.72%

  • Geode Capital Management, LLC

    0.80%

  • Renaissance Technologies Corp

    0.45%

  • Northern Trust Corp

    0.36%

Analyst Recommendation on Marker Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Marker Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Marker Therapeutics

What analysts predicted

Upside of 508.97%

Current:

$3.12

Target:

$19.00

Insights on Marker Therapeutics

  • Price Movement

    In the last 7 days, MRKR stock has moved down by -1.5%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.16M → 1.92M (in $), with an average increase of 39.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -2.19M → -2.30M (in $), with an average decrease of 5.3% per quarter
  • MRKR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 55.4%
  • MRKR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 116.9%
  • Price to Sales

    ForMRKR every $1 of sales, investors are willing to pay $7.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Marker Therapeutics Technicals Summary

Sell

Neutral

Buy

Marker Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Marker Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Marker Therapeutics Inc
-15.42%
-33.54%
-33.4%
-60.85%
-88.54%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Marker Therapeutics Inc
NA
NA
NA
-1.05
-0.72
-0.41
NA
1.58
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Marker Therapeutics Inc
Buy
$33.3M
-88.54%
NA
-278.22%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Marker Therapeutics

tapimmune is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. the company’s next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches and has the potential to be a powerful standalone therapy or part of a leading combination regimen by complementing other approved or development-stage immunotherapeutics (i.e. checkpoint inhibitors). the company’s off-the-shelf vaccines boost patients’ immune systems to comprehensively stimulate both killer t-cells and helper t-cells to destroy cancer cells, and they are designed to work with 80% of the population. tapimmune is advancing two clinical stage t-cell vaccine candidates in multiple phase ii and phase ib/iia clinical trials for treating ovarian and breast cancers, including programs in ovarian cancer that will benefit from fda fast track and orphan disease designation. the company is working in collaboration with industry and clini
Organization
Marker Therapeutics
Employees
8
CEO
Dr. Juan F. Vera M.D.
Industry
Consumer Services

Management People of Marker Therapeutics

NameTitle
Dr. Juan F. Vera M.D.
Co-Founder, CEO, President, Treasurer, Secretary & Director
Ms. Elizabeth Donnelly
Director of Administration
Dr. Maria-Bernadette Madel
Director of Corporate Operations & External Communications
Mr. Edmund Cheung
Vice President of Human Resources
Dr. Monic Stuart M.D.
Chief Medical Officer
Patricia Allison
Head of Clinical Operations
Ms. Mary Newman Ph.D.
Head of Regulatory Affairs
Dr. Robert Z. Florkiewicz Sr.
Senior Director of Molecular Biology & Virology

Important FAQs about investing in Marker Therapeutics from India :

What is Marker Therapeutics share price today?

Marker Therapeutics share price today stands at $3.12, Open: $3.29 ; Previous Close: $3.29 ; High: $3.23 ; Low: $3.03 ; 52 Week High: $5.99 ; 52 Week Low: $2.44. The stock opens at $3.29, after a previous close of $3.29. The stock reached a daily high of $3.23 and a low of $3.03, with a 52-week high of $5.99 and a 52-week low of $2.44.

Can Indians buy Marker Therapeutics shares?

Yes, Indians can invest in the Marker Therapeutics (MRKR) from India.

With INDmoney, you can buy Marker Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Marker Therapeutics at zero transaction cost.

How can I buy Marker Therapeutics shares from India?

It is very easy to buy Marker Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Marker Therapeutics be purchased?

Yes, you can buy fractional shares of Marker Therapeutics with INDmoney app.

What are the documents required to start investing in Marker Therapeutics stocks?

To start investing in Marker Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Marker Therapeutics

Today’s highest price of Marker Therapeutics (MRKR) is $3.23.

Today’s lowest price of Marker Therapeutics (MRKR) is $3.03.

What is today's market capitalisation of Marker Therapeutics

Today's market capitalisation of Marker Therapeutics MRKR is 33.3M

What is the 52 Week High and Low Range of Marker Therapeutics

  • 52 Week High

    $5.99

  • 52 Week Low

    $2.44

What are the historical returns of Marker Therapeutics?

  • 1 Month Returns

    -15.42%

  • 3 Months Returns

    -33.54%

  • 1 Year Returns

    -33.4%

  • 5 Years Returns

    -88.54%

Who is the Chief Executive Officer (CEO) of Marker Therapeutics

Dr. Juan F. Vera M.D. is the current Chief Executive Officer (CEO) of Marker Therapeutics.